These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1131 related articles for article (PubMed ID: 22280073)
1. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain. Ibáñez R; Moreno-Crespi J; Sardà M; Autonell J; Fibla M; Gutiérrez C; Lloveras B; Alejo M; Català I; Alameda F; Casas M; Bosch FX; de Sanjosé S BMC Infect Dis; 2012 Jan; 12():25. PubMed ID: 22280073 [TBL] [Abstract][Full Text] [Related]
2. Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types. Verdoodt F; Szarewski A; Halfon P; Cuschieri K; Arbyn M Cancer Cytopathol; 2013 Dec; 121(12):675-87. PubMed ID: 23881840 [TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559 [TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus test with cytology triage in organized screening for cervical cancer. Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407 [TBL] [Abstract][Full Text] [Related]
5. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program. Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891 [TBL] [Abstract][Full Text] [Related]
6. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084 [TBL] [Abstract][Full Text] [Related]
7. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand. Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Suprasert P; Siriaunkgul S Asian Pac J Cancer Prev; 2014; 15(24):10961-6. PubMed ID: 25605209 [TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology. Peeters E; Wentzensen N; Bergeron C; Arbyn M Cancer Cytopathol; 2019 Mar; 127(3):169-180. PubMed ID: 30811902 [TBL] [Abstract][Full Text] [Related]
9. Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study. Ogilvie GS; Krajden M; van Niekerk DJ; Martin RE; Ehlen TG; Ceballos K; Smith LW; Kan L; Cook DA; Peacock S; Stuart GC; Franco EL; Coldman AJ Br J Cancer; 2012 Dec; 107(12):1917-24. PubMed ID: 23169286 [TBL] [Abstract][Full Text] [Related]
10. Clinical performance of the aptima HPV assay in 4196 women with positive high-risk HPV and ASC-US cytology: A large women hospital experience. Wang T; Pradhan D; Zhang H; Matsko J; Zhao C Diagn Cytopathol; 2021 Jan; 49(1):5-10. PubMed ID: 32857920 [TBL] [Abstract][Full Text] [Related]
11. Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening. Cuzick J; Adcock R; Carozzi F; Gillio-Tos A; De Marco L; Del Mistro A; Frayle H; Girlando S; Sani C; Confortini M; Zorzi M; Giorgi-Rossi P; Rizzolo R; Ronco G; Int J Cancer; 2020 Oct; 147(7):1864-1873. PubMed ID: 32170961 [TBL] [Abstract][Full Text] [Related]
12. Immediate histologic correlation in women with atypical squamous cells of undetermined significance cytology and positive high-risk HPV: A retrospective review of 6000 cases in a large academic women's hospital. Zhang H; Pradhan D; Wang T; Ashman D; Matsko J; Zhao C Cancer Cytopathol; 2020 Nov; 128(11):852-859. PubMed ID: 32639689 [TBL] [Abstract][Full Text] [Related]
13. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status]. Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846 [No Abstract] [Full Text] [Related]
15. Efficacy of optical coherence tomography in the triage of women with minor abnormal cervical cytology before colposcopy. Yan L; Xiao X; He L; Shi L; Yang X; Zhang J; Zhang Y; Fu C PLoS One; 2023; 18(3):e0282833. PubMed ID: 36913396 [TBL] [Abstract][Full Text] [Related]
16. BD-ProExC as adjunct molecular marker for improved detection of CIN2+ after HPV primary screening. Depuydt CE; Makar AP; Ruymbeke MJ; Benoy IH; Vereecken AJ; Bogers JJ Cancer Epidemiol Biomarkers Prev; 2011 Apr; 20(4):628-37. PubMed ID: 21297040 [TBL] [Abstract][Full Text] [Related]
17. The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy. Arbyn M; Roelens J; Cuschieri K; Cuzick J; Szarewski A; Ratnam S; Reuschenbach M; Belinson S; Belinson JL; Monsonego J Int J Cancer; 2013 Jan; 132(1):101-8. PubMed ID: 22610699 [TBL] [Abstract][Full Text] [Related]
18. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China. Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450 [TBL] [Abstract][Full Text] [Related]
19. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting. Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051 [TBL] [Abstract][Full Text] [Related]
20. Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping. Hernández-López R; Lorincz AT; Torres-Ibarra L; Reuter C; Scibior-Bentkowska D; Warman R; Nedjai B; Mendiola-Pastrana I; León-Maldonado L; Rivera-Paredez B; Ramírez-Palacios P; Lazcano-Ponce E; Cuzick J; Salmerón J; Clin Epigenetics; 2019 Oct; 11(1):140. PubMed ID: 31606044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]